Anesthesiology Manual:
Best Practices and Case Management

Major thoracic surgery, particularly esophagectomy, carries a substantial risk of postoperative morbidity. Clinicians have long explored goal-directed fluid therapy (GDT) and hemodynamic optimization as strategies to improve outcomes. A new randomized controlled trial published in Anesthesiology (2026) challenges this paradigm, showing that even highly individualized perioperative blood pressure and fluid strategies may not reduce complications. Overview of the study This prospective, single-blind randomized controlled trial evaluated whether extending individualized hemodynamic management beyond surgery improves outcomes. Study design Population: 100 patients undergoing esophagectomy Intervention: Extended goal-directed fluid therapy (eGDT) Individualized mean arterial pressure (MAP) targets based on preoperative nighttime blood pressure Control: Standard hemodynamic care Duration of intervention: From anesthesia induction to the first postoperative morning Primary outcome Comprehensive complication index (CCI) at 30 days Key findings No reduction in complications CCI score: eGDT: 39.0 ± 20.0 Standard care: 39.2 ± 21.0 No statistically or clinically significant difference Increased intervention without benefit Patients in the individualized group experienced: Higher fluid administration Increased norepinephrine use Slightly higher mean arterial pressure Despite these changes: No improvement in postoperative morbidity No difference in hospital or ICU length of stay  Complication burden remained high 98% of patients in the intervention group had at least one complication 96% in standard care Over 460 complications recorded at 30 days What is goal-directed fluid therapy? Goal-directed fluid therapy (GDT) aims to optimize: Cardiac output Tissue perfusion Oxygen delivery Traditional approach Uses dynamic parameters such as: Stroke volume variation (SVV) Cardiac output monitoring Often applies fixed MAP thresholds (e.g., ≥65 mmHg) What makes this study different? This trial introduced two key innovations: Individualized blood pressure targets MAP targets derived from each patient’s baseline nighttime blood pressure Range typically between 65–85 mmHg Extended therapy into postoperative period Continued hemodynamic optimization until the morning after surgery Addresses: Fluid shifts ICU hemodynamic […]

Maternal cardiac arrest (MCA) during the peripartum period remains one of the most critical emergencies in obstetric medicine. A newly published multicenter cohort study in Anesthesiology (2026) provides one of the most comprehensive analyses to date, offering detailed insights into incidence, etiology, risk factors, and management during anesthetic care. Overview of the study This large retrospective cohort study analyzed 778,102 deliveries across 60 U.S. institutions between 2015 and 2022. The investigation focused specifically on cardiac arrest occurring during or within 7 days of anesthetic care. Key findings Incidence: 11.2 per 100,000 deliveries (~1 in 9,000) Total cases identified: 87 confirmed maternal cardiac arrests Survival outcomes: Return of spontaneous circulation (ROSC): 77% 30-day survival: 67.8% Primary causes: Hemorrhage: 40.2% Amniotic fluid embolism (AFE): 31.0% Anesthesia-related arrests: 11.5% of cases  What is maternal cardiac arrest? Maternal cardiac arrest refers to the cessation of effective cardiac output during pregnancy or postpartum, resulting in loss of perfusion to vital organs. Clinical definition Absence of pulse or cardiac activity Requires Advanced Cardiac Life Support (ACLS) interventions Occurs during pregnancy or within 42 days postpartum (in broader definitions) Incidence and timing When do cardiac arrests occur? The study revealed important timing patterns: 62.1% occurred after delivery 20.7% occurred before delivery 85% occurred within 12 hours postpartum Median onset: 26 minutes after delivery Location of arrest Operating room: 81.6% Labor ward: 10.3% Post-anesthesia care unit: 4.6% Major causes of maternal cardiac arrest Obstetric hemorrhage The leading cause of MCA: Accounts for 40.2% of cases Often associated with: Placenta accreta spectrum (PAS) Placental abruption Surgical complications Clinical significance: Despite lower ROSC rates compared to AFE, patients who achieved ROSC after hemorrhagic arrest had excellent survival outcomes. Amniotic fluid embolism (AFE) Second most common cause: Represents 31% of cases Rapid onset, often within minutes of delivery Characterized by: Cardiovascular […]